⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
QNTM News
Quantum Biopharma Ltd. Class B Subordinate Voting Shares
Quantum BioPharma: Engineering the Digital Balance Sheet in Life Sciences A Vanderbilt Report View
accessnewswire.com
QNTM
Quantum BioPharma Announces the Record Date for the Distribution of a Special Dividend of Contingent Value Rights (CVRs) Tied to the Future Litigation Settlement Proceeds of its USD $700 Million+ Case
globenewswire.com
QNTM
Quantum BioPharma Receives Final Reports for Two Key Studies of its Potential Breakthrough Drug for Multiple Sclerosis, Moving Closer to Phase 2 Clinical Trial
globenewswire.com
QNTM
Quantum BioPharma Welcomes World-Renowned Multiple Sclerosis Expert Dr. Jack Antel as Clinical Development Advisor For Lucid-MS Trials
globenewswire.com
QNTM
Quantum BioPharma Ltd. Announces Results of Annual General and Special Meeting of Shareholders
globenewswire.com
QNTM